Print Page   |   Your Cart   |   Sign In   |   Join
New Directions in Influenza Management
Register Tell a Friend About This EventTell a Friend
 

 Export to Your Calendar 10/27/2020
When: Tuesday October 27, 2020
5-6 pm
Where: United States


Online registration is available until: 10/27/2020
« Go to Upcoming Event List  

Differentiating influenza from other viruses and treating high-risk patients in a timely manner to avoid overburdening the healthcare system, has never been more relevant. Join us for a timely, expert-led CPE program that will marry the current data and guideline recommendations on influenza testing, diagnosis, and an viral treatment with engaging whiteboard animation on case studies, so you are prepared to apply the latest updates in influenza to clinical practice now.

Faculty: Katherine Lusardi, PharmD., Clinical Pharmacy Specialist, Antimicrobial Stewardship, UAMS Medical Center, Little Rock, AR

Katherine T. Lusardi, PharmD, is the Clinical Pharmacy Specialist for Antimicrobial Stewardship at the UAMS Medical Center in Little Rock, Arkansas. She has been at UAMS for 9 years, after finishing a PGY2 in infectious diseases with the University of Houston and Cardinal Health.

Dr. Lusardi is engaged in teaching, serving as a preceptor at the UAMS and VAMC PGY1 Pharmacy Residencies, and for the UAMS College of Pharmacy. She is involved nationally with ACCP and the ACCP ID PRN, having previously served as faculty for the inaugural BCIDP study course. In October, she will receive the award for ACCP ID PRN Clinical Practitioner of the Year.

Learning Objectives
Upon proper completion of this activity, participants should be better able to:

  • Identify appropriate candidates for antiviral therapy based on risk for influenza-related complications, in accordance with current guideline recommendations
  • Assess the need for influenza treatment based on patient signs, symptoms, and accurate interpretation of appropriate diagnostic tests when necessary
  • Recommend individualized antiviral treatment plans for patients with, or at risk for, influenza in accordance with the latest evidence


This CE activity is jointly provided by ProCE, Inc. and Paradigm Medical Communications, LLC. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-243-L01-P has been assigned to this live knowledge-based CE activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of the evaluation and the post-test are required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

For a copy of the flyer

more Calendar

10/27/2020
Webinar: Build Your Business by Developing an Inside Sales Team - It's Easier Than You Think!

10/27/2020
WSPA Compounding Special Interest Group

Online Surveys
1402 - ICU Medical Inc Campaign
Association Management Software Powered by YourMembership  ::  Legal